Document is current
Any future updates will be listed below
-
Authors
Weiler, Daniela https://orcid.org/0009-0007-8059-7861
Pérez Lago, Maria del Sol https://orcid.org/0009-0001-1955-2716
- License Information
-
More Information
Article History
Received: 29 February 2024
Accepted: 28 April 2024
First Online: 20 May 2024
Declarations
:
: Libretto-001 trial has ethics approval.
: Written informed consent was obtained from the patient.
: Daniela Weiler has received speaker and consultant honoraria from Eli Lilly. Maria del Sol Pérez Lago declares no financial interests.
